Health Care: Drugs

Seattle Genetics Inc (SGEN: NASDAQ)

$32 n/a | n/a%
12/26/14 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 32.00
52 Week High 55.99
52 Week Low 30.50
Avg. Daily Vol. (Mil) 1.39
Beta (3 year) 2.26
Share Related Items
Mkt Cap (Mil) 3,964.53
Shares Out (Mil) 123.89
Float (Mil) 69.39
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 3.20
Current Ratio 3.60
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 14.17
Price/Book 17.61
Price/Cash Flow -75.60
Per Share Data
Earnings -0.53
Sales 2.26
Book Value 1.82
Cash Flow -0.42
Business Summary
Seattle Genetics Inc is a biotechnology company. It develops and commercializes monoclonal antibody-based therapies for the treatment of cancer and autoimmune disease.
General Information
21823 - 30th Drive South Eas
Bothell, WA 98021
www.seattlegenetics.com
Industry : Drugs
Sector: Health Care
Employees: 582
CEO: Dr. Clay B. Siegall,PhD
Short Interest
Current Month (Mil) 19.98
Previous Month (Mil) 18.73
Short Interest Ratio (Days) 14.70
Management Effectiveness
Return on Equity n.a.
Return on Assets -13.60
Return on Investments -28.90
Profitability
Gross Margin 94.80
EBIT Margin -23.30
Profit Margin -23.30

Portfolios with SGEN

Latest SGEN Headlines from TheStreet

More Financial News for SGEN

Press Releases for SGEN

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter